Keyt Bruce 4
4 · IGM Biosciences, Inc. · Filed May 25, 2023
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-05-15$11.71/sh+960$11,242→ 139,040 total - Sale
Common Stock
2023-05-23$13.01/sh−12$156→ 138,058 total - Sale
Common Stock
2023-05-23$12.30/sh−970$11,931→ 138,070 total
Holdings
- 1,013(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]This transaction was executed in multiple trades at prices ranging from $12.00 to $12.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]This transaction was executed in multiple trades at prices ranging from $13.00 to $13.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F5]The shares are held directly by the Reporting Person's spouse.